Law360, New York (May 21, 2007, 12:00 AM EDT) -- After encountering a roadblock in its long-running patent feud with Novartis AG, Teva Pharmaceutical Industries Ltd. said late Monday that a federal district court had vacated a temporary restraining order it had issued on Saturday that barred the Israeli generics maker from shipping a generic version of the drug.
The order, entered on Saturday in the U.S. District Court for the District of New Jersey, granted Novartis’ emergency request for a temporary order barring Teva's launch of its generic Lotrel product in connection with the Swiss...
Court Lifts Order Barring Teva’s Generic Lotrel
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
